AnGes, Inc. (4563.T)
JPY 78.0
(5.41%)
JPY 78.0
(5.41%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -3.79 Billion JPY | 61.56% |
| 2022 | -9.87 Billion JPY | 44.81% |
| 2021 | -17.89 Billion JPY | -55.15% |
| 2020 | -11.53 Billion JPY | -14.9% |
| 2019 | -10.04 Billion JPY | -73.57% |
| 2018 | -5.78 Billion JPY | -404.02% |
| 2017 | -1.14 Billion JPY | -15.28% |
| 2016 | -995.62 Million JPY | 52.02% |
| 2015 | -2.07 Billion JPY | 65.52% |
| 2014 | -6.01 Billion JPY | -235.18% |
| 2013 | -1.79 Billion JPY | -406.02% |
| 2012 | -354.77 Million JPY | 77.48% |
| 2011 | -1.57 Billion JPY | 26.8% |
| 2010 | -2.15 Billion JPY | 39.36% |
| 2009 | -3.54 Billion JPY | 43.66% |
| 2008 | -6.29 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -1.48 Billion JPY | 15.78% |
| 2024 Q1 | -1.76 Billion JPY | 53.57% |
| 2023 Q1 | -8.4 Billion JPY | 14.91% |
| 2023 Q2 | -6.62 Billion JPY | 21.24% |
| 2023 FY | -3.79 Billion JPY | 61.56% |
| 2023 Q4 | -3.79 Billion JPY | 20.98% |
| 2023 Q3 | -4.8 Billion JPY | 27.41% |
| 2022 Q3 | -10.05 Billion JPY | 23.91% |
| 2022 Q2 | -13.21 Billion JPY | 14.27% |
| 2022 Q1 | -15.41 Billion JPY | 13.9% |
| 2022 FY | -9.87 Billion JPY | 44.81% |
| 2022 Q4 | -9.87 Billion JPY | 1.72% |
| 2021 Q2 | -23.81 Billion JPY | -68.25% |
| 2021 Q3 | -21.14 Billion JPY | 11.25% |
| 2021 Q4 | -17.89 Billion JPY | 15.33% |
| 2021 FY | -17.89 Billion JPY | -55.15% |
| 2021 Q1 | -14.15 Billion JPY | -22.71% |
| 2020 FY | -11.53 Billion JPY | -14.9% |
| 2020 Q3 | -12.31 Billion JPY | 9.12% |
| 2020 Q2 | -13.55 Billion JPY | -45.45% |
| 2020 Q4 | -11.53 Billion JPY | 6.33% |
| 2020 Q1 | -9.31 Billion JPY | 7.2% |
| 2019 Q4 | -10.04 Billion JPY | 6.79% |
| 2019 FY | -10.04 Billion JPY | -73.57% |
| 2019 Q1 | -9.49 Billion JPY | -64.07% |
| 2019 Q2 | -11.29 Billion JPY | -18.96% |
| 2019 Q3 | -10.77 Billion JPY | 4.59% |
| 2018 Q3 | -3.49 Billion JPY | -41.26% |
| 2018 Q1 | -1.45 Billion JPY | -26.82% |
| 2018 Q2 | -2.47 Billion JPY | -69.87% |
| 2018 FY | -5.78 Billion JPY | -404.02% |
| 2018 Q4 | -5.78 Billion JPY | -65.62% |
| 2017 Q2 | -1.83 Billion JPY | -106.14% |
| 2017 FY | -1.14 Billion JPY | -15.28% |
| 2017 Q4 | -1.14 Billion JPY | 13.03% |
| 2017 Q3 | -1.31 Billion JPY | 28.15% |
| 2017 Q1 | -890.95 Million JPY | 10.51% |
| 2016 Q3 | -1.68 Billion JPY | 30.01% |
| 2016 Q1 | -861.94 Million JPY | 58.46% |
| 2016 FY | -995.62 Million JPY | 52.02% |
| 2016 Q4 | -995.62 Million JPY | 41.05% |
| 2016 Q2 | -2.41 Billion JPY | -179.95% |
| 2015 Q1 | -5.18 Billion JPY | 13.88% |
| 2015 FY | -2.07 Billion JPY | 65.52% |
| 2015 Q3 | -3.37 Billion JPY | 28.23% |
| 2015 Q2 | -4.7 Billion JPY | 9.15% |
| 2015 Q4 | -2.07 Billion JPY | 38.59% |
| 2014 Q1 | -1.88 Billion JPY | -5.2% |
| 2014 Q4 | -6.01 Billion JPY | 15.68% |
| 2014 Q3 | -7.13 Billion JPY | -273.85% |
| 2014 Q2 | -1.9 Billion JPY | -1.07% |
| 2014 FY | -6.01 Billion JPY | -235.18% |
| 2013 Q2 | -1.5 Billion JPY | -6.98% |
| 2013 Q3 | -2.02 Billion JPY | -34.54% |
| 2013 Q4 | -1.79 Billion JPY | 11.34% |
| 2013 FY | -1.79 Billion JPY | -406.02% |
| 2013 Q1 | -1.4 Billion JPY | -296.56% |
| 2012 Q4 | -354.77 Million JPY | 26.63% |
| 2012 Q3 | -483.56 Million JPY | 49.58% |
| 2012 Q2 | -959.12 Million JPY | 19.03% |
| 2012 Q1 | -1.18 Billion JPY | 24.82% |
| 2012 FY | -354.77 Million JPY | 77.48% |
| 2011 FY | -1.57 Billion JPY | 26.8% |
| 2011 Q3 | -1.96 Billion JPY | 6.96% |
| 2011 Q2 | -2.1 Billion JPY | 0.07% |
| 2011 Q4 | -1.57 Billion JPY | 19.71% |
| 2011 Q1 | -2.11 Billion JPY | 1.94% |
| 2010 Q2 | -3.11 Billion JPY | 2.14% |
| 2010 Q1 | -3.17 Billion JPY | 10.41% |
| 2010 FY | -2.15 Billion JPY | 39.36% |
| 2010 Q3 | -2.57 Billion JPY | 17.18% |
| 2010 Q4 | -2.15 Billion JPY | 16.48% |
| 2009 Q3 | -3.92 Billion JPY | 34.16% |
| 2009 FY | -3.54 Billion JPY | 43.66% |
| 2009 Q2 | -5.96 Billion JPY | -2.83% |
| 2009 Q1 | -5.79 Billion JPY | 0.0% |
| 2009 Q4 | -3.54 Billion JPY | 9.58% |
| 2008 FY | -6.29 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 742.75 Million JPY | 611.303% |
| PRISM BioLab Co.,LTD | -1.13 Billion JPY | -234.915% |
| GNI Group Ltd. | -17.93 Billion JPY | 78.823% |
| Linical Co., Ltd. | -4.46 Billion JPY | 14.911% |
| Trans Genic Inc. | -221.16 Million JPY | -1617.125% |
| MEDINET Co., Ltd. | -4.39 Billion JPY | 13.57% |
| Soiken Holdings Inc. | -4.79 Billion JPY | 20.715% |
| Cytori Cell Research Institute, Inc. | 1.43 Billion JPY | 364.922% |
| OncoTherapy Science, Inc. | -420.8 Million JPY | -802.492% |
| Nxera Pharma Co., Ltd. | 24.9 Billion JPY | 115.247% |
| Immuno-Biological Laboratories Co., Ltd. | -498.15 Million JPY | -662.364% |
| NanoCarrier Co., Ltd. | -466.34 Million JPY | -714.361% |
| Carna Biosciences, Inc. | -2.7 Billion JPY | -40.339% |
| CanBas Co., Ltd. | -1.88 Billion JPY | -101.131% |
| D. Western Therapeutics Institute, Inc. | -982.14 Million JPY | -286.68% |
| RaQualia Pharma Inc. | -3.39 Billion JPY | -11.796% |
| Chiome Bioscience Inc. | -1.03 Billion JPY | -267.09% |
| Kidswell Bio Corporation | 343.58 Million JPY | 1205.317% |
| PeptiDream Inc. | 3.29 Billion JPY | 215.363% |
| Oncolys BioPharma Inc. | -972.59 Million JPY | -290.477% |
| Ribomic Inc. | -2.09 Billion JPY | -80.867% |
| SanBio Company Limited | -3.78 Billion JPY | -0.212% |
| Healios K.K. | -2.19 Billion JPY | -73.413% |
| BrightPath Biotherapeutics Co., Ltd. | -944.85 Million JPY | -301.938% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -2.62 Billion JPY | -44.723% |
| Delta-Fly Pharma, Inc. | -1.41 Billion JPY | -168.002% |
| StemRIM | -8.41 Billion JPY | 54.842% |
| CellSource Co., Ltd. | -4.68 Billion JPY | 18.912% |
| FunPep Company Limited | -1.79 Billion JPY | -111.765% |
| Kringle Pharma, Inc. | -2.13 Billion JPY | -77.756% |
| Stella Pharma Corporation | -1.11 Billion JPY | -239.265% |
| TMS Co., Ltd. | -3.44 Billion JPY | -10.187% |
| Noile-Immune Biotech Inc. | -5.55 Billion JPY | 31.642% |
| Cuorips Inc. | -5.56 Billion JPY | 31.708% |
| K Pharma,Inc. | -3.26 Billion JPY | -16.267% |
| Takara Bio Inc. | -32.2 Billion JPY | 88.207% |
| ReproCELL Incorporated | -2.93 Billion JPY | -29.217% |
| PhoenixBio Co., Ltd. | -660.96 Million JPY | -474.581% |
| StemCell Institute Inc. | -2.83 Billion JPY | -33.876% |
| Japan Tissue Engineering Co., Ltd. | -2.06 Billion JPY | -83.791% |
| CellSeed Inc. | -2.01 Billion JPY | -88.751% |